These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2012137)
1. Retrospective survey of urea cycle disorders: Part 1. Clinical and laboratory observations of thirty-two Japanese male patients with ornithine transcarbamylase deficiency. Matsuda I; Nagata N; Matsuura T; Oyanagi K; Tada K; Narisawa K; Kitagawa T; Sakiyama T; Yamashita F; Yoshino M Am J Med Genet; 1991 Jan; 38(1):85-9. PubMed ID: 2012137 [TBL] [Abstract][Full Text] [Related]
2. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency. Matsuda I; Tanase S Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation. Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299 [TBL] [Abstract][Full Text] [Related]
5. Urea cycle disorders in Thai infants: a report of 5 cases. Wasant P; Srisomsap C; Liammongkolkul S; Svasti J J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252 [TBL] [Abstract][Full Text] [Related]
6. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. McBride KL; Miller G; Carter S; Karpen S; Goss J; Lee B Pediatrics; 2004 Oct; 114(4):e523-6. PubMed ID: 15466081 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthesis in ornithine transcarbamylase deficiency: possible involvement of low no synthesis in clinical manifestations of urea cycle defect. Nagasaka H; Komatsu H; Ohura T; Sogo T; Inui A; Yorifuji T; Murayama K; Takayanagi M; Kikuta H; Kobayashi K J Pediatr; 2004 Aug; 145(2):259-62. PubMed ID: 15289781 [TBL] [Abstract][Full Text] [Related]
9. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family. Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466 [TBL] [Abstract][Full Text] [Related]
10. Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency. Cavicchi C; Malvagia S; la Marca G; Gasperini S; Donati MA; Zammarchi E; Guerrini R; Morrone A; Pasquini E J Pharm Biomed Anal; 2009 Jul; 49(5):1292-5. PubMed ID: 19359120 [TBL] [Abstract][Full Text] [Related]
11. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia. Tuchman M; Yudkoff M Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
13. Hereditary urea cycle diseases in Finland. Keskinen P; Siitonen A; Salo M Acta Paediatr; 2008 Oct; 97(10):1412-9. PubMed ID: 18616627 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical analysis of carbamyl phosphate synthetase I and ornithine transcarbamylase deficient livers: elevated N-acetylglutamate level in a liver lacking carbamyl phosphate synthetase protein. Zhang W; Holzknecht RA; Butkowski RJ; Tuchman M Clin Invest Med; 1990 Aug; 13(4):183-8. PubMed ID: 2208834 [TBL] [Abstract][Full Text] [Related]
15. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Gyato K; Wray J; Huang ZJ; Yudkoff M; Batshaw ML Ann Neurol; 2004 Jan; 55(1):80-6. PubMed ID: 14705115 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of patients with late onset ornithine transcarbamylase deficiency. Tuchman M; Holzknecht RA Clin Invest Med; 1991 Aug; 14(4):320-4. PubMed ID: 1782729 [TBL] [Abstract][Full Text] [Related]
17. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes. Marini JC; Erez A; Castillo L; Lee B Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451 [TBL] [Abstract][Full Text] [Related]
18. Ornithine transcarbamylase deficiency. Yeh SJ; Hou WL; Tsai WS; Wu TJ; Tuchman M; Wang TR J Formos Med Assoc; 1997 Jan; 96(1):43-5. PubMed ID: 9033181 [TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical characteristics of patients with urea cycle disorders in a developing country. Ibarra-González I; Fernández-Lainez C; Vela-Amieva M Clin Biochem; 2010 Mar; 43(4-5):461-6. PubMed ID: 20025860 [TBL] [Abstract][Full Text] [Related]
20. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency. Climent C; Rubio V Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]